Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Clinical trial NCT07064018 · RECRUITING

Trial details

NCT number: NCT07064018
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Soft-tissue Sarcoma Triple Negative Breast Cancer Non-small Cell Lung Cancer Cervical Cancer Ovarian Cancer KRAS Mutation-Related Tumors

Start date: 2025-04-30
Primary completion: 2029-12-31
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.